Alto Neuroscience (ANRO) Debt Ratio (2023 - 2026)

Alto Neuroscience has disclosed Debt Ratio across 4 years of filings, most recently posting 0.06 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.06, down 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.06 (down 50.0% YoY), and the FY2025 annual result was 0.09, up 57.1% from the prior year.
• Debt Ratio came in at 0.06 for Q1 2026 at Alto Neuroscience, down from 0.09 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.14 in Q3 2025 to a low of 0.05 in Q1 2024.
• The 4-year median for Debt Ratio is 0.07 (2026), against an average of 0.09.
• Across the five-year window, Debt Ratio surged 160.71% in 2025 and tumbled 50.0% in 2026, its largest moves.
• Alto Neuroscience's Debt Ratio stood at 0.11 in 2023, then slumped by 49.26% to 0.06 in 2024, then soared by 57.1% to 0.09 in 2025, then sank by 36.08% to 0.06 in 2026.
• The last three Debt Ratio figures came in at 0.06 (Q1 2026), 0.09 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.